Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
16.05
-0.66 (-3.95%)
At close: Dec 12, 2025, 4:00 PM EST
16.04
-0.01 (-0.06%)
After-hours: Dec 12, 2025, 7:16 PM EST
Apollomics Market Cap
Apollomics has a market cap or net worth of $34.45 million as of December 12, 2025. Its market cap has increased by 136.22% in one year.
Market Cap
34.45M
Enterprise Value
25.63M
1-Year Change
136.22%
Ranking
Category
Stock Price
$16.05
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $34.45M, a decrease of -73.42%. That is a compound annual growth rate of -27.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 34.45M | 220.40% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.78B |
| Johnson & Johnson | 505.98B |
| AbbVie | 395.86B |
| UnitedHealth Group | 305.02B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 245.75B |
| Novo Nordisk | 223.42B |